Instytut Psychiatrii I Neurologii
Warsaw, Poland
Treatment & access
- Treatments offeredEsketamine nasal spray (Spravato®)
- Access routeCovered by a national programme
- Cost & coverage (registry status)Covered by NFZ (drug programme B.147)
- ReimbursementNFZ drug programme B.147 - leczenie chorych na depresję lekooporną How reimbursement works in Europe →
- Phone+48 22 45 82 800
- Websitehttps://ipin.edu.pl/
Languages spoken
As stated by the provider on its own website: each language links to the exact page and wording it was verified against.
- Polish Sign Language (PJM) (patient support / interpreting, not the therapy language) Source
Related listings
These records belong to the same organisation. They are listed separately because each is a distinct programme or location.
- Another programme at this clinicDepartment of Pharmacology and Physiology of CNS : Clinical trials
About this provider
The Institute of Psychiatry and Neurology (Instytut Psychiatrii i Neurologii, IPiN) at ul. Sobieskiego 9 in Warsaw's Mokotów district is, per its own site, Poland's largest research centre developing new methods of treating and rehabilitating mental and neurological disorders. Per NFZ data it provides esketamine for treatment-resistant depression under the fully funded NFZ program B.147. The Institute combines inpatient psychiatric and neurological care, outpatient clinics with e-registration, modern diagnostics, and clinical research programs, allowing new therapeutic approaches to be implemented directly in patient care.
Services & programs
- Inpatient psychiatric and neurological treatment (leczenie szpitalne)
- Outpatient clinics (leczenie w poradni) with e-registration
- Modern diagnostic facilities for mental and nervous system disorders
- Clinical research and specialist programs for diagnosis and treatment of mental disorders
- NFZ drug program B.147, esketamine for treatment-resistant depression (per NFZ data)
Common questions
How do I get esketamine treatment at IPiN?
A referral from a psychiatrist is required. Qualification follows the B.147 program criteria: age 18-75 and moderate to severe treatment-resistant depression after at least two adequately conducted antidepressant treatments. Contact the Institute's exchange at 22 45 82 800 or use e-registration at erejestracja.ipin.edu.pl.
Does the treatment cost anything?
No. Program B.147 is fully funded by NFZ, esketamine (Spravato) sessions, administration and the required observation are free for eligible patients, for up to 34 weeks.
What is the waiting time?
Per NFZ data (as of June 2026), the first available date was 2026-07-01, with no patients in the queue.
2 more verified providers within 50 km
- Ząbki · 14 km"Mazowiecki Szpital Wojewódzki Drewnica" Sp. Z O.O. : Spravato®
- Pruszków · 16 kmMazowieckie Specjalistyczne Centrum Zdrowia Im.Prof. Jana Mazurkiewicza W Pruszkowie : Spravato®
Verification
- License / registryNFZ B.147
- Official registryhttps://api.nfz.gov.pl/app-itl-api/queues?case=1&benefit=LECZENIE%20CHORYCH%20NA%20DEPRESJ%C4%98%20LEKOOPORN%C4%84&provider=Instytut%20Psychiatrii%20I%20Neurologii&format=json
- Last verified
Check your fit & enquire
Check my fit & enquireWhat to prepare before you enquire
- A referral or the contact details of your treating clinician
- A list of medications you have tried (names, doses, duration)
- A short diagnosis summary or discharge letters